• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者T细胞的改变:特异性从何而来?

Alterations in T cells of cancer-bearers: whence specificity?

作者信息

Levey D L, Srivastava P K

机构信息

Dept of Biological Sciences, Fordham University, Bronx, NY 10458, USA.

出版信息

Immunol Today. 1996 Aug;17(8):365-8. doi: 10.1016/0167-5699(96)10013-X.

DOI:10.1016/0167-5699(96)10013-X
PMID:8783496
Abstract

T cells of tumor-bearing mice and cancer patients have been reported to have altered signal-transduction machinery. These alterations have been implicated in immunological suppression. Here, Daniel Levey and Pramod Srivastava critically examine the evidence for these alterations in the context of the tumor specificity of immunological unresponsiveness in tumor-bearing hosts.

摘要

据报道,荷瘤小鼠和癌症患者的T细胞具有改变的信号转导机制。这些改变与免疫抑制有关。在此,丹尼尔·利维(Daniel Levey)和普拉莫德·斯里瓦斯塔瓦(Pramod Srivastava)在荷瘤宿主免疫无反应性的肿瘤特异性背景下,严格审查了这些改变的证据。

相似文献

1
Alterations in T cells of cancer-bearers: whence specificity?癌症患者T细胞的改变:特异性从何而来?
Immunol Today. 1996 Aug;17(8):365-8. doi: 10.1016/0167-5699(96)10013-X.
2
Sequential development of structural and functional alterations in T cells from tumor-bearing mice.荷瘤小鼠T细胞结构和功能改变的序贯性发展
J Immunol. 1997 Jun 1;158(11):5292-6.
3
Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.Lyt-2+ T细胞在美法仑治愈的MOPC-315肿瘤荷瘤小鼠对MOPC-315肿瘤细胞攻击的抗性中的重要性。
Cancer Res. 1988 Sep 1;48(17):4834-42.
4
Alterations in signal transducing molecule CD3 zeta in patients with neoplastic diseases.肿瘤疾病患者信号转导分子CD3ζ的改变。
Arch Immunol Ther Exp (Warsz). 1998;46(6):355-9.
5
Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.美法仑诱导携带大型MOPC - 315肿瘤的成年BALB/c小鼠胸腺细胞抗肿瘤免疫反应增强。
Cancer Res. 1987 Sep 15;47(18):4848-55.
6
Alteration of signal transduction in T cells from cancer patients.癌症患者T细胞中信号转导的改变。
Important Adv Oncol. 1995:43-54.
7
T and B lymphocyte migration into syngeneic tumors.T淋巴细胞和B淋巴细胞向同基因肿瘤的迁移。
J Immunol. 1977 Mar;118(3):1042-8.
8
Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.抗肿瘤免疫反应中的树突状细胞。I. 荷瘤宿主中抗原呈递缺陷。
Cell Immunol. 1996 May 25;170(1):101-10. doi: 10.1006/cimm.1996.0139.
9
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes.免疫功能低下的荷瘤小鼠在T和B淋巴细胞中表现出STAT5a/b表达的选择性丧失。
J Immunol. 1997 Sep 15;159(6):2580-5.
10
[Immunological properties of tumor cells that determine the degree of their malignancy].[决定肿瘤细胞恶性程度的免疫特性]
Usp Sovrem Biol. 1981;91(2):228-40.

引用本文的文献

1
Novel bioinformatic approaches show the role of driver genes in the progression of cervical cancer: An in-silico study.新型生物信息学方法揭示驱动基因在宫颈癌进展中的作用:一项计算机模拟研究。
Heliyon. 2024 Nov 14;10(22):e40179. doi: 10.1016/j.heliyon.2024.e40179. eCollection 2024 Nov 30.
2
A pharmacologic perspective on newly emerging T-cell manipulation technologies.新兴 T 细胞操控技术的药理学视角。
Br J Clin Pharmacol. 2013 Aug;76(2):173-87. doi: 10.1111/j.1365-2125.2012.04475.x.
3
Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy.
口腔癌患者 T 细胞免疫反应和信号转导蛋白的增强:白细胞介素 2 介导的免疫治疗的潜力。
J Cancer Res Clin Oncol. 2011 Oct;137(10):1435-44. doi: 10.1007/s00432-011-1012-2. Epub 2011 Aug 2.
4
Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine.肿瘤疫苗治疗后 CD8 区中干细胞相关基因的早期表达。
Cell Immunol. 2010;265(1):65-73. doi: 10.1016/j.cellimm.2010.07.004. Epub 2010 Jul 17.
5
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.在严重联合免疫缺陷(SCID)小鼠异种移植模型中,过继转移的人肺肿瘤特异性细胞毒性T细胞可以控制自体肿瘤生长并塑造肿瘤表型。
J Transl Med. 2007 Jun 25;5:29. doi: 10.1186/1479-5876-5-29.
6
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.有效的抗肿瘤免疫疗法需要什么?以单核细胞增生李斯特菌作为人乳头瘤病毒相关肿瘤的活载体所获得的经验教训。
Cancer Immunol Immunother. 2005 Jun;54(6):577-86. doi: 10.1007/s00262-004-0600-2. Epub 2005 Jan 14.
7
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.免疫治疗逃逸:影响肿瘤消退/进展的可能机制
Cancer Immunol Immunother. 2004 Oct;53(10):844-54. doi: 10.1007/s00262-004-0540-x. Epub 2004 Jun 10.
8
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.通过工程改造使其表达嵌合受体基因的淋巴细胞对肿瘤细胞的靶向作用。
Cancer Immunol Immunother. 2004 Oct;53(10):893-903. doi: 10.1007/s00262-004-0523-y. Epub 2004 May 26.
9
Alleviating oxidative stress in cancer immunotherapy: a role for histamine?减轻癌症免疫治疗中的氧化应激:组胺的作用?
Med Oncol. 2000 Nov;17(4):258-69. doi: 10.1007/BF02782190.
10
The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.细胞毒性T淋巴细胞在肿瘤预防和免疫监视中的作用——来自正常和免疫缺陷小鼠的经验教训。
Med Oncol. 1999 Dec;16(4):223-38. doi: 10.1007/BF02785868.